Tom Darlington

Tom has 20+ years experience in nanomaterial fabrication & development, chemistry, composite research, analytical assay development, and molecular & cell biology. He joined nanoComposix in 2005 after working with Epicyte Pharmaceuticals to rapidly scale antibody manufacturing with novel expression systems and with Chromatin, Inc. to develop analytical tools for characterizing biological macromolecules.

At nanoComposix, Tom has developed technology in the areas of plasmonic nanoparticles (photothermal treatment, signature management, color perception), biomolecule-targeted nanoparticles (cancer therapy & imaging), lateral flow devices (Lyme disease vector in ticks), materials science (self-healing carbon fiber composites, thermal interface materials, transparent conductive thin films), and instruments (gold nanoparticles for MALDI imaging, single cell mass spectrometer (SCMS) based on ATOFMS technology).

Tom is currently focused on transferring projects from early stage R&D into regulated development and manufacturing programs. He established the nanoComposix Quality Management System (QMS) and built an ISO Class 8 manufacturing suite for the production of nanomaterials for medical devices. Examples of medical device products manufactured for clients at nanoComposix under the QMS include topical silver particles used in photothermal treatment (Sienna Biopharmaceuticals) and lateral flow test strips for mapping loiasis (Drugs & Diagnostics for Tropical Diseases).